Meningitis test kit

infectioncontaminationblood

Kriba has developed a non-invasive and automatic transfontanellar cerebrospinal fluid white blood cell counter for newborns and infants meningitis screening and monitoring, to reduce negative lumbar punctures and democratize access to early detection around the world. This is an investigational device. It is not for sale. The claims made on this website have not been evaluated by the FDA or the CE Mark authorities. Kriba generates impact on healthcare worldwide by accelerating non-invasive screening, diagnosis and monitoring of infant meningitis Meningitis suspicion is challenging due to unspecific signs of the infection, such as fever of an unknown source, especially in infants and newborns who are the most vunerable, and may exhibit minimal symptomatology.
 History and physical examination alone are often insufficient to confirm or exclude the diagnosis of infant meningitis. Lumbar puncture, the current gold standard procedure for screening is invasive, can be difficult to perform and may carry some risk. Neosonics© non-invasively counts white blood cells in cerebrospinal fluid below the infant fontanelle, offering a quick, easy, and cost-effective way to confirm or rule out suspicion of infant meningitis. In high-income countries with low incidence of the disease, Neosonics© reduces negative lumbar punctures to only positive cases, sparing most suspected patients from the invasive procedure. Routine lumbar punctures for infant meningitis screening turn out negative in most cases, and results are frequently delayed due to contamination with blood.